Correction: Molecular profile of BRCA-mutated biliary tract cancers

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Matthias Preusser, Hannah Christina Puhr, Anna Sophie Berghoff, Thorsten Fuereder, Florian Moik, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Julia Maria Berger, Judith Kreminger, Lorenz Schubert, Angelika Martina Starzer, Ariane Steindl, Stefan Winkler, Selma Tobudic
التنسيق:	مقال
اللغة:	English
منشور في:	Elsevier 2020-10-01
سلاسل:	ESMO Open
الوصول للمادة أونلاين:	https://esmoopen.bmj.com/content/5/5/e000682corr1.full

مواد مشابهة

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
حسب: Matthias Preusser, وآخرون
منشور في: (2020-10-01)

Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
حسب: Angelika M. Starzer, وآخرون
منشور في: (2022-04-01)

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial
حسب: Maximilian J. Mair, وآخرون
منشور في: (2023-02-01)

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
حسب: Matthias Preusser, وآخرون
منشور في: (2022-03-01)

New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
حسب: Anna S. Berghoff, وآخرون
منشور في: (2019-06-01)

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up
حسب: Selma Tobudic, وآخرون
منشور في: (2022-07-01)

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
حسب: Thomas Perkmann, وآخرون
منشور في: (2023-08-01)

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination
حسب: Selma Tobudic, وآخرون
منشور في: (2023-02-01)

Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
حسب: Elisabeth Sophie Bergen, وآخرون
منشور في: (2021-04-01)

New developments in brain metastases
حسب: Anna S. Berghoff, وآخرون
منشور في: (2018-06-01)

Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases
حسب: Markus Kleinberger, وآخرون
منشور في: (2025-02-01)

Surveillance of respiratory syncytial virus infections in adults, Austria, 2017 to 2019
حسب: Lorenz Schubert, وآخرون
منشور في: (2021-04-01)

Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222
حسب: Thomas Perkmann, وآخرون
منشور في: (2021-09-01)

Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
حسب: Thomas Perkmann, وآخرون
منشور في: (2021-09-01)

Evaluation of the Septifast MGrade Test on Standard Care Wards--A Cohort Study.
حسب: Franz Ratzinger, وآخرون
منشور في: (2016-01-01)

Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases
حسب: Jagoda Pokryszka, وآخرون
منشور في: (2022-05-01)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
حسب: Melissa S Cline, وآخرون
منشور في: (2018-12-01)

SARS-CoV-2 infections in “less visible” hospital staff: The roles and safety of environmental services and allied health professionals
حسب: Sebastian Jensen, وآخرون
منشور في: (2023-09-01)

The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study
حسب: Thomas Perkmann, وآخرون
منشور في: (2022-02-01)

Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma
حسب: Matthias Preusser, وآخرون
منشور في: (2020-05-01)

Correction: Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’
حسب: Matthias Preusser, وآخرون
منشور في: (2020-05-01)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
حسب: Kara N. Maxwell, وآخرون
منشور في: (2017-08-01)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
حسب: Yuichiro Hatano, وآخرون
منشور في: (2020-03-01)

Epistatic relationships in the BRCA1-BRCA2 pathway.
حسب: Ralph Scully
منشور في: (2011-07-01)

Influence of Five Potential Anticancer Drugs on Wnt Pathway and Cell Survival in Human Biliary Tract Cancer Cells
حسب: Julia WACHTER, Daniel NEUREITER, Beate ALINGER, Martin PICHLER, Julia FUEREDER, Christian OBERDANNER, Pietro Di FAZIO, Matthias OCKER, Frieder BERR, Tobias KIESSLICH
منشور في: (2012-01-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
حسب: Pankaja Umarane, وآخرون
منشور في: (2023-03-01)

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
حسب: Qianyan Li, وآخرون
منشور في: (2021-04-01)

Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population: insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria
حسب: Eva S Schernhammer, وآخرون
منشور في: (2023-01-01)

The Modern Approaches and Future Perspectives on Breast and Ovarian Cancer Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers: A Literature Overview
حسب: Sandra Sarnacka, وآخرون
منشور في: (2024-05-01)

Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer
حسب: Cornelia Englisch, وآخرون
منشور في: (2023-10-01)

Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency
حسب: Lisa Göschl, وآخرون
منشور في: (2022-09-01)

Human Borrelia miyamotoi Infection, Austria
حسب: Selma Tobudic, وآخرون
منشور في: (2020-09-01)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
حسب: Osman K., وآخرون
منشور في: (2022-12-01)

Roles of BRCA1 and BRCA2 in DNA replication and genome stability
حسب: Zimmer, J
منشور في: (2017)

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
حسب: M. M. Tsyganov, وآخرون
منشور في: (2020-07-01)

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
حسب: A. A. Kashintsev, وآخرون
منشور في: (2016-02-01)

Genetic Variation of The BRCA1 and BRCA2 Genes in Macedonian Patients
حسب: Plaseska-Karanfilska Dijana, وآخرون
منشور في: (2012-12-01)

Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
حسب: Ilirjana Bajrami, وآخرون
منشور في: (2021-11-01)

Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes
حسب: Stella Lai, وآخرون
منشور في: (2015-01-01)

Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
حسب: McKinley Joanne M, وآخرون
منشور في: (2007-09-01)